Ausgabe 1/2010
Inhalt (35 Artikel)
Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
P. C. Butler, A. V. Matveyenko, S. Dry, A. Bhushan, R. Elashoff
The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation
H. Kolb, T. Mandrup-Poulsen
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
A. E. Butler, R. Galasso, A. Matveyenko, R. A. Rizza, S. Dry, P. C. Butler
Efficacy of leptin therapy in the different forms of human lipodystrophy
A. Y. Chong, B. C. Lupsa, E. K. Cochran, P. Gorden
Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients
E. Vandemeulebroucke, B. Keymeulen, K. Decochez, I. Weets, C. De Block, F. Féry, U. Van de Velde, I. Vermeulen, P. De Pauw, C. Mathieu, D. G. Pipeleers, F. K. Gorus
Telomere length predicts all-cause mortality in patients with type 1 diabetes
A. S. Astrup, L. Tarnow, A. Jorsal, M. Lajer, R. Nzietchueng, A. Benetos, P. Rossing, H.-H. Parving
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study
E. Ritz, G. C. Viberti, L. M. Ruilope, A. J. Rabelink, J. L. Izzo Jr, S. Katayama, S. Ito, A. Mimran, J. Menne, L. C. Rump, A. Januszewicz, H. Haller
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus
E. van den Berg, Y. D. Reijmer, J. de Bresser, R. P. C. Kessels, L. J. Kappelle, G. J. Biessels
Short-form measures of diabetes-related emotional distress: the Problem Areas in Diabetes Scale (PAID)-5 and PAID-1
B. E. McGuire, T. G. Morrison, N. Hermanns, S. Skovlund, E. Eldrup, J. Gagliardino, A. Kokoszka, D. Matthews, M. Pibernik-Okanović, J. Rodríguez-Saldaña, M. de Wit, F. J. Snoek
Differential relationship between physical activity and progression to diabetes by glucose tolerance status: the Inter99 Study
S. Engberg, C. Glümer, D. R. Witte, T. Jørgensen, K. Borch-Johnsen
HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study
E. L. M. Barr, A. J. Cameron, B. Balkau, P. Z. Zimmet, T. A. Welborn, A. M. Tonkin, J. E. Shaw
Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort
D. A. Lawlor, A. Fraser, R. S. Lindsay, A. Ness, D. Dabelea, P. Catalano, G. Davey Smith, N. Sattar, S. M. Nelson
The interferon-induced helicase IFIH1 Ala946Thr polymorphism is associated with type 1 diabetes in both the high-incidence Finnish and the medium-incidence Hungarian populations
A. Jermendy, I. Szatmári, A. P. Laine, K. Lukács, K. H. Horváth, A. Körner, L. Madácsy, R. Veijola, O. Simell, M. Knip, J. Ilonen, R. Hermann
Genetic association analysis of LARS2 with type 2 diabetes
E. Reiling, B. Jafar-Mohammadi, E. van ’t Riet, M. N. Weedon, J. V. van Vliet-Ostaptchouk, T. Hansen, R. Saxena, T. W. van Haeften, P. A. Arp, S. Das, G. Nijpels, M. J. Groenewoud, E. C. van Hove, A. G. Uitterlinden, J. W. A. Smit, A. D. Morris, A. S. F. Doney, C. N. A. Palmer, C. Guiducci, A. T. Hattersley, T. M. Frayling, O. Pedersen, P. E. Slagboom, D. M. Altshuler, L. Groop, J. A. Romijn, J. A. Maassen, M. H. Hofker, J. M. Dekker, M. I. McCarthy, L. M. ’t Hart
Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys
Y. Saisho, A. E. Butler, E. Manesso, R. Galasso, L. Zhang, T. Gurlo, G. M. Toffolo, C. Cobelli, K. Kavanagh, J. D. Wagner, P. C. Butler
OVO homologue-like 1 (Ovol1) transcription factor: a novel target of neurogenin-3 in rodent pancreas
A. Vetere, W.-C. Li, F. Paroni, K. Juhl, L. Guo, W. Nishimura, X. Dai, S. Bonner-Weir, A. Sharma
Regulation of wingless-type MMTV integration site family (WNT) signalling in pancreatic islets from wild-type and obese mice
J. Krützfeldt, M. Stoffel
Single pancreatic beta cells co-express multiple islet hormone genes in mice
H. Katsuta, T. Akashi, R. Katsuta, M. Nagaya, D. Kim, Y. Arinobu, M. Hara, S. Bonner-Weir, A. J. Sharma, K. Akashi, G. C. Weir
Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise
E. Y. H. Khoo, J. Wallis, K. Tsintzas, I. A. Macdonald, P. Mansell
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics
A. Tura, S. Sbrignadello, E. Succurro, L. Groop, G. Sesti, G. Pacini
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
J. S. Nachnani, D. G. Bulchandani, A. Nookala, B. Herndon, A. Molteni, P. Pandya, R. Taylor, T. Quinn, L. Weide, L. M. Alba
Diabetes regulates mitochondrial biogenesis and fission in mouse neurons
J. L. Edwards, A. Quattrini, S. I. Lentz, C. Figueroa-Romero, F. Cerri, C. Backus, Y. Hong, E. L. Feldman
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis
Y. Pham, Y. Tu, T. Wu, T. J. Allen, A. C. Calkin, A. M. Watson, J. Li, K. A. Jandeleit-Dahm, B-H. Toh, Z. Cao, M. E. Cooper, Z. Chai
Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes
Y. F. Dong, L. Liu, K. Kataoka, T. Nakamura, M. Fukuda, Y. Tokutomi, H. Nako, H. Ogawa, S. Kim-Mitsuyama
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
A. M. D. Watson, J. Li, C. Schumacher, M. de Gasparo, B. Feng, M. C. Thomas, T. J. Allen, M. E. Cooper, K. A. M. Jandeleit-Dahm
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues
D. Simon
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine
J. M. Nagel, U. Mansmann, K. Wegscheider, J. Röhmel
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues. Reply to Nagel JM, Mansmann U, Wegscheider K et al. [letter] and Simon D [letter]
U. Grouven, L. G. Hemkens, R. Bender, P. T. Sawicki
Using individual patient data in meta-analyses of glucose-lowering studies
J. S. Yudkin, B. Richter
Erratum to: Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro
S. K. Pinnamaneni, R. J. Southgate, M. A. Febbraio, M. J. Watt